Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1990 Apr;47(4):277–280. doi: 10.1136/oem.47.4.277

Cerebrospinal fluid proteins and free amino acids in patients with solvent induced chronic toxic encephalopathy and healthy controls.

B E Moen 1, K R Kyvik 1, B A Engelsen 1, T Riise 1
PMCID: PMC1035150  PMID: 2337535

Abstract

The concentrations of protein, albumin, IgG, and free amino acids in the cerebrospinal fluid of 16 patients with chronic toxic encephalopathy due to organic solvents were measured. The patient group consisted of all patients with this diagnosis in a neurological department in 1985. The diagnosis was based on neuraesthenic symptoms, pathological psychometric performance, and verified exposure to neurotoxic organic solvents. A control group of 16 patients with myalgias or backache, or both, and no signs of disease was used for comparison. The purpose was to study possible changes in the cerebrospinal fluid that might contribute to understanding the aetiology of solvent induced chronic toxic encephalopathy. A rise in protein, albumin, and IgG was found in the patient group compared with the control group, as well as reduced concentrations of phosphoethanolamine, taurine, homocarnosine, ethanolamine, alpha-aminobutyric acid, and leucine. Using a stepwise multiple regression analysis, taurine was negatively correlated to exposure to solvents. These findings may indicate membrane alterations in the central nervous system related to exposure to organic solvents.

Full text

PDF
277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arlien-Søborg P., Bruhn P., Gyldensted C., Melgaard B. Chronic painters' syndrome. Chronic toxic encephalopathy in house painters. Acta Neurol Scand. 1979 Sep;60(3):149–156. [PubMed] [Google Scholar]
  2. Axelson O., Hane M., Hogstedt C. Neuropsykiatriska sjukdomstillstånd hos lösningsmedelsexponerade arbetare -- en case-control-studie. Lakartidningen. 1976 Jan 28;73(5):322–325. [PubMed] [Google Scholar]
  3. Barbeau A., Inoue N., Tsukada Y., Butterworth R. F. The neuropharmacology of taurine. Life Sci. 1975 Sep 1;17(5):669–677. doi: 10.1016/0024-3205(75)90520-2. [DOI] [PubMed] [Google Scholar]
  4. Gjessing L. R., Gjesdahl P., Sjaastad O. The free amino acids in human cerebrospinal fluid. J Neurochem. 1972 Jul;19(7):1807–1808. doi: 10.1111/j.1471-4159.1972.tb06226.x. [DOI] [PubMed] [Google Scholar]
  5. Honma T., Hasegawa H., Sato M., Sudo A. Changes of free amino acid content in rat brain after exposure to trichloroethylene and tetrachloroethylene. Ind Health. 1980;18(1):1–7. doi: 10.2486/indhealth.18.1. [DOI] [PubMed] [Google Scholar]
  6. Juntunen J., Antti-Poika M., Tola S., Partanen T. Clinical prognosis of patients with diagnosed chronic solvent intoxication. Acta Neurol Scand. 1982 May;65(5):488–503. doi: 10.1111/j.1600-0404.1982.tb03105.x. [DOI] [PubMed] [Google Scholar]
  7. Lehmann A., Hamberger A. A possible interrelationship between extracellular taurine and phosphoethanolamine in the hippocampus. J Neurochem. 1984 May;42(5):1286–1290. doi: 10.1111/j.1471-4159.1984.tb02785.x. [DOI] [PubMed] [Google Scholar]
  8. Mikkelsen S., Jørgensen M., Browne E., Gyldensted C. Mixed solvent exposure and organic brain damage. A study of painters. Acta Neurol Scand Suppl. 1988;118:1–143. [PubMed] [Google Scholar]
  9. Orbaek P., Risberg J., Rosén I., Haeger-Aronsen B., Hagstadius S., Hjortsberg U., Regnell G., Rehnström S., Svensson K., Welinder H. Effects of long-term exposure to solvents in the paint industry. A cross-sectional epidemiologic study with clinical and laboratory methods. Scand J Work Environ Health. 1985;11 (Suppl 2):1–28. [PubMed] [Google Scholar]
  10. Perry T. L., Bratty P. J., Hansen S., Kennedy J., Urquhart N., Dolman C. L. Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol. 1975 Feb;32(2):108–113. doi: 10.1001/archneur.1975.00490440058009. [DOI] [PubMed] [Google Scholar]
  11. Perry T. L., Hansen S., Kennedy J. CSF amino acids and plasma--CSF amino acid ratios in adults. J Neurochem. 1975 Mar;24(3):587–589. doi: 10.1111/j.1471-4159.1975.tb07680.x. [DOI] [PubMed] [Google Scholar]
  12. Perschak H., Wolfensberger M., Do K. Q., Dunant Y., Cuénod M. Release of ethanolamine, but not of serine or choline, in rat pontine nuclei on stimulation of afferents from the cortex, in vivo. J Neurochem. 1986 May;46(5):1338–1343. doi: 10.1111/j.1471-4159.1986.tb01744.x. [DOI] [PubMed] [Google Scholar]
  13. Wikkelsø C., Ekberg K., Lillienberg L., Wetterholm B., Karlsson B., Blomstrand C., Johansson B. B. Cerebrospinal fluid proteins and cells in men subjected to long-term exposure to organic solvents. Acta Neurol Scand Suppl. 1984;100:113–119. [PubMed] [Google Scholar]
  14. Wright C. E., Tallan H. H., Lin Y. Y., Gaull G. E. Taurine: biological update. Annu Rev Biochem. 1986;55:427–453. doi: 10.1146/annurev.bi.55.070186.002235. [DOI] [PubMed] [Google Scholar]
  15. Yanai Y., Shibasaki T., Kohno N., Mitsui T., Nakajima H. Concentrations of sulfur-containing free amino acids in lumbar cerebrospinal fluid from patients with consciousness disturbances. Acta Neurol Scand. 1983 Dec;68(6):386–393. doi: 10.1111/j.1600-0404.1983.tb04848.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES